Both companies aim to improve the efficiency and success rate of the current drug discovery process.
He will be stationed at the company HQ in Bengaluru, India
Takeda Will Focus its Efforts on Dengue, Zika and Pandemic vaccines
The TWYMEEG approval is supported by numerous preclinical and clinical studies, including the Phase 3 TIMES (Trials of IMeglimin for Efficacy and Safety) program managed jointly by both the companies
Entered into a manufacturing partnership with Ocugen, Inc. for manufacturing of COVID-19 vaccine COVAXIN for the US and Canadian markets
AdCOVID is a COVID-19 vaccine candidate that is administered via nasal spray.
_256_384.jpg)
The company expects to generate an EBITDA margin before special items of around 27 percent in 2021.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
